Kemp Dolliver Stock Analyst Profile - Brookline Capital Research Coverage - Stocknear

Kemp Dolliver

Stock Analyst at Brookline Capital

(1.78)
# 3331
Out of 5,493 analysts
27
Total ratings
Success rate
Average return

21 Stocks

Name Action PT Current % Upside Ratings Updated
RNTX Rein Therapeutics
Downgrades: Hold
n/a
n/a n/a 1 Aug 19, 2025
RADX Radiopharm Theranost...
Initiates Coverage On: Buy
18
5.75 213.04% 1 Jul 21, 2025
LSTA Lisata Therapeutics
Maintains: Strong Buy
20 32
2.47 1195.55% 1 Jul 15, 2025
YMAB Y-mAbs Therapeutics
Initiates Coverage On: Buy
17
8.61 97.44% 1 Dec 5, 2024
EYEN Eyenovia
Downgrades: Hold
n/a
n/a n/a 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.81 344.44% 1 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
36
2.09 1622.49% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Mar 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
32
0.97 3137.11% 1 Jan 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
27 13
n/a n/a 1 Dec 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
50.61 97.59% 1 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
57
2.49 2189.16% 2 Oct 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
5
n/a n/a 1 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
25
4.2 495.24% 1 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
4.93 280.32% 1 Jan 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
8
1.07 647.66% 1 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.03 448.54% 1 Feb 2, 2022